Change in Brain Glucose After Enteral Nutrition in Subarachnoid Hemorrhage

Kinoshita, Kosaku; Moriya, Takuya; Utagawa, Akira; Sakurai, Atsushi; Mukoyama, Takeo; Furukawa, Masashi; Yamaguchi, Junko; Tanjoh, Katsuhisa

doi:10.1016/j.jss.2009.06.009

Cited by 14 publications

(15 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They can trigger pulmonary edema and congestive heart failure in susceptible patients, especially when used in conjunction with insulin. For this reason, they are contraindicated in patients classified as New York Heart Association class 3 and 4 congestive heart failure [36, 38]. TZDs should be restarted only after postoperative recovery is complete and there is no evidence of cardiopulmonary compromise or fluid overload [14, 15, 30, 36, 37].…”

Section: Causes Of Glucose Variations During the Perioperative Permentioning

confidence: 99%

“…A strategy of blood glucose control should include a nutrition protocol with the preferential use of the enteral route [8, 14, 15, 35, 38, 91]. Initiating blood glucose control without adequate provision of calories and carbohydrates will increase the risk of hypoG [8, 14, 15, 35, 38, 91].…”

Section: Glucose Variability and Monitoringmentioning

confidence: 99%

“…Initiating blood glucose control without adequate provision of calories and carbohydrates will increase the risk of hypoG [8, 14, 15, 35, 38, 91]. This strategy of strict blood glucose control should be carefully coordinated with the level of nutritional support and metabolic status, which changes frequently in neurocritically ill patients.…”

Section: Glucose Variability and Monitoringmentioning

confidence: 99%

“…This strategy of strict blood glucose control should be carefully coordinated with the level of nutritional support and metabolic status, which changes frequently in neurocritically ill patients. A recent study, evaluated the nutrition protocol's influence on brain metabolism using microdialysis in patients with SAH [38]. Two hours after 250 Kcal by nasojejunal tube feeding, there were simultaneous increments in glucose levels in the blood and cerebral extracellular space without a change of glutamate concentration or the L/P ratio [38].…”

Section: Glucose Variability and Monitoringmentioning

confidence: 99%

“…A recent study, evaluated the nutrition protocol's influence on brain metabolism using microdialysis in patients with SAH [38]. Two hours after 250 Kcal by nasojejunal tube feeding, there were simultaneous increments in glucose levels in the blood and cerebral extracellular space without a change of glutamate concentration or the L/P ratio [38]. Stress hyperG exacerbates the disorders in gastric motility as a result of several factors such as cytokines produced by inflammation, oxidative stress, vasoactive intestinal peptides, splanchnic hypoperfusion, and drugs such as phenytoin, steroids, and opioids [91].…”

Section: Glucose Variability and Monitoringmentioning

confidence: 99%

See 4 more Smart Citations

Perioperative Glucose Control in Neurosurgical Patients

Godoy

Napoli²,

Biestro

et al. 2012

Anesthesiology Research and Practice

View full text Add to dashboard Cite

Many neurosurgery patients may have unrecognized diabetes or may develop stress-related hyperglycemia in the perioperative period. Diabetes patients have a higher perioperative risk of complications and have longer hospital stays than individuals without diabetes. Maintenance of euglycemia using intensive insulin therapy (IIT) continues to be investigated as a therapeutic tool to decrease morbidity and mortality associated with derangements in glucose metabolism due to surgery. Suboptimal perioperative glucose control may contribute to increased morbidity, mortality, and aggravate concomitant illnesses. The challenge is to minimize the effects of metabolic derangements on surgical outcomes, reduce blood glucose excursions, and prevent hypoglycemia. Differences in cerebral versus systemic glucose metabolism, time course of cerebral response to injury, and heterogeneity of pathophysiology in the neurosurgical patient populations are important to consider in evaluating the risks and benefits of IIT. While extremes of glucose levels are to be avoided, there are little data to support an optimal blood glucose level or recommend a specific use of IIT for euglycemia maintenance in the perioperative management of neurosurgical patients. Individualized treatment should be based on the local level of blood glucose control, outpatient treatment regimen, presence of complications, nature of the surgical procedure, and type of anesthesia administered.

show abstract

Section: Causes Of Glucose Variations During the Perioperative Permentioning

confidence: 99%

Section: Glucose Variability and Monitoringmentioning

confidence: 99%

Section: Glucose Variability and Monitoringmentioning

confidence: 99%

Section: Glucose Variability and Monitoringmentioning

confidence: 99%

Section: Glucose Variability and Monitoringmentioning

confidence: 99%

See 3 more Smart Citations

Perioperative Glucose Control in Neurosurgical Patients

Godoy

Napoli²,

Biestro

et al. 2012

Anesthesiology Research and Practice

View full text Add to dashboard Cite

show abstract

Blood Glucose Concentration Management in Neuro-Patients

Bilotta

Stazi

2017

Challenging Topics in Neuroanesthesia and Neurocritical Care

View full text Add to dashboard Cite

Consensus statement from the 2014 International Microdialysis Forum

et al. 2015

View full text Add to dashboard Cite

Microdialysis enables the chemistry of the extracellular interstitial space to be monitored. Use of this technique in patients with acute brain injury has increased our understanding of the pathophysiology of several acute neurological disorders. In 2004, a consensus document on the clinical application of cerebral microdialysis was published. Since then, there have been significant advances in the clinical use of microdialysis in neurocritical care. The objective of this review is to report on the International Microdialysis Forum held in Cambridge, UK, in April 2014 and to produce a revised and updated consensus statement about its clinical use including technique, data interpretation, relationship with outcome, role in guiding therapy in neurocritical care and research applications.Electronic supplementary materialThe online version of this article (doi:10.1007/s00134-015-3930-y) contains supplementary material, which is available to authorized users.

show abstract

Change in Brain Glucose After Enteral Nutrition in Subarachnoid Hemorrhage

Cited by 14 publications

References 21 publications

Perioperative Glucose Control in Neurosurgical Patients

Perioperative Glucose Control in Neurosurgical Patients

Blood Glucose Concentration Management in Neuro-Patients

Consensus statement from the 2014 International Microdialysis Forum

Contact Info

Product

Resources

About